Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study. | Sao Paulo Med J | 2025 | 40834163 | PubTator, text mining | PubMed |
| The ATF4-glutamine axis: a central node in cancer metabolism, stress adaptation, and therapeutic targeting. | Cell Death Discov | 2025 | 40830338 | PubTator, text mining | PubMed |
| Liver X receptor agonists in central nervous system disorders: From neuroprotection to clinical challenges. | Neuroscience | 2025 | 40783035 | PubTator, text mining | PubMed |
| Intracellular cholesterol: new functions and therapeutic approaches in NSCLC EGFR-TKI resistance. | Lipids Health Dis | 2025 | 40739632 | PubTator, text mining | PubMed |
| Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols. | Food Sci Nutr | 2025 | 40735395 | PubTator, text mining | PubMed |
| Correlation of specific addictions with cancer sites identified among patients in Northeast India. | Sci Rep | 2025 | 40731140 | PubTator, text mining | PubMed |
| Liver X receptors: A therapeutic target in demyelinating disorders. | Pharmacol Res | 2025 | 40695410 | PubTator, text mining | PubMed |
| APOE4-driven lipid metabolic dysregulation in Alzheimer's disease: Multi-pathway mechanisms and therapeutic perspectives. | Biochem Biophys Res Commun | 2025 | 40669336 | PubTator, text mining | PubMed |
| Cold exposure promotes the progression of osteoarthritis through downregulating APOE in cartilage. | EMBO Mol Med | 2025 | 40664892 | PubTator, text mining | PubMed |
| Bridging prediction and reality: Comprehensive analysis of experimental and AlphaFold 2 full-length nuclear receptor structures. | Comput Struct Biotechnol J | 2025 | 40496892 | PubTator, text mining | PubMed |
| Mediterranean Diet Modulates Gene Expression of Cholesterol Efflux Receptors in High-Risk Cardiovascular Patients. | Mol Nutr Food Res | 2025 | 40344371 | PubTator, text mining | PubMed |
| Exploring the Roles of Liver X Receptors in Lipid Metabolism and Immunity in Atherosclerosis. | Biomolecules | 2025 | 40305368 | PubTator, text mining | PubMed |
Calycosin-7-Glucoside Alleviates Atherosclerosis by Inhibiting Ox-LDL-Induced Foam Cell Formation and Inflammatory Response in THP-1-Derived Macrophages via ATF-1 Activation Through the p38/MAPK Pathway. | J Inflamm Res | 2025 | 40303003 | PubTator, text mining | PubMed |
| Action of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors on ABCA-1 protein (ATP-Binding Cassette Transporter-1) in endothelial cells stimulated with uremic serum. | Lipids Health Dis | 2025 | 40108621 | PubTator, text mining | PubMed |
| Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2. | ACS Pharmacol Transl Sci | 2025 | 40046426 | PubTator, text mining | PubMed |
| Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction. | Nat Commun | 2025 | 40025008 | PubTator, text mining | PubMed |
| Ganaxolone Reverses the Effect of Amyloid β-Induced Neurotoxicity by Regulating the Liver X Receptor Expression in APP Transfected SH-SY5Y Cells and Murine Model of Alzheimer's Disease. | J Neurochem | 2025 | 39936324 | PubTator, text mining | PubMed |
| Upregulation of LXRβ/ABCA1 pathway alleviates cochlear hair cell senescence of C57BL/6 J mice via reducing lipid droplet accumulation. | Biogerontology | 2025 | 39890652 | PubTator, text mining | PubMed |
| Triterpenoids from Chios Mastiha Resin Against MASLD-A Molecular Docking Survey. | Curr Issues Mol Biol | 2025 | 39852166 | PubTator, text mining | PubMed |
PFAS (per- and polyfluorinated alkyl substances) as EDCs (endocrine-disrupting chemicals) - Identification of compounds with high potential to bind to selected terpenoids NHRs (nuclear hormone receptors). | Chemosphere | 2025 | 39694292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=3